Optimizing Key Lentiviral CMC & Analytical Approaches
Time: 9:00 am - 12:00 pm
day: Workshop A
Several gene therapies are being developed using lentiviral vectors, and it’s clear from regulatory feedback that quality and characterization of lentiviral gene therapy products are an absolute
must when gearing up for any approval, and there are learnings to be made across the gene therapy field regardless which vector type being worked in. Whether you work in lentiviral vectors or not, this workshop will give a solid grounding in analytical and CMC techniques to meet regulatory expectations.
Attend this workshop to learn about:
- Defining key quality attributes for lentiviral vectors
- How translatable are AAV and lentiviral product characterization methods?
- Streamlining CMC and regulatory interactions to meet current regulatory guidelines